Biopharmaceutical Stock Flat Despite Upgrade to "Buy"

The firm also lifted its price target to $74 from $66

Deputy Editor
Apr 13, 2021 at 9:13 AM
facebook X logo linkedin


The shares of biopharmaceutical name Bristol-Myers Squibb Co (NYSE:BMY) are up 0.6% at $63.07 in pre-market trading, after Truist Securities upgraded the stock to "buy" from hold," with a price-target hike to $74 from $66. The analyst in coverage cited late-stage pipeline assets, also noting the FDA's recent approval of multiple treatments.

On the charts, both the 40- and 140-day moving averages moved in as support in mid-March -- recently catching the equity's pullback after it was rejected by the $64 level. Year-to-date, the equity is up just 1.1% coming into today. 

Analysts were already leaning bullish ahead of today's upgrade, though there's still some room for additional upgrades. Of the 14 analysts in coverage, five carried a tepid "hold" rating, with the remaining nine at a "buy" or better. Meanwhile, the 12-month consensus price target of $75.88 is a 21% premium to last night's close. 

Over in the options pits, 4.06 calls have been bought for every put in the last 50 days at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This ratio stands higher than 69% of all other readings from the past year, indicating calls being picked up at a reasonably fast rate. 

Lastly, now looks like a decent time to weigh in on BMY's next move with options. The stock's Schaeffer's Volatility Index (SVI) of 21% stands higher than 20% of readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment. 

 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI